These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29153540)

  • 21. Human papillomavirus detection in cervical carcinoma tissues and paraaortic lymph nodes by the polymerase chain reaction.
    Park JS; Chee YH; Namkoong SE; Han SK; Kim TE; Lee HY; Kim SJ
    Gynecol Oncol; 1994 Jun; 53(3):344-51. PubMed ID: 8206408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individual and geographic disparities in human papillomavirus types 16/18 in high-grade cervical lesions: Associations with race, ethnicity, and poverty.
    Niccolai LM; Russ C; Julian PJ; Hariri S; Sinard J; Meek JI; McBride V; Markowitz LE; Unger ER; Hadler JL; Sosa LE
    Cancer; 2013 Aug; 119(16):3052-8. PubMed ID: 23661284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection of human papillomavirus and overexpression of dihydrodiol dehydrogenase in uterine cervical cancer.
    Ueda M; Hung YC; Chen JT; Chiou SH; Huang HH; Lin TY; Terai Y; Chow KC
    Gynecol Oncol; 2006 Aug; 102(2):173-81. PubMed ID: 16427687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPV status in sentinel nodes might be a prognostic factor in cervical cancer.
    Lee YS; Rhim CC; Lee HN; Lee KH; Park JS; Namkoong SE
    Gynecol Oncol; 2007 May; 105(2):351-7. PubMed ID: 17275890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV genotyping from invasive cervical cancer in Chile.
    Roa JC; Garcia P; Gomez J; Fernández W; Gaete F; Espinoza A; Lepetic A; Suarez E
    Int J Gynaecol Obstet; 2009 May; 105(2):150-3. PubMed ID: 19249046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
    Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
    Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
    [No Abstract]   [Full Text] [Related]  

  • 27. Oncogenic human papilloma virus and cervical pre-cancerous lesions in brothel-based sex workers in India.
    Sarkar K; Bhattacharya S; Bhattacharyya S; Chatterjee S; Mallick AH; Chakraborti S; Chatterjee D; Bal B
    J Infect Public Health; 2008; 1(2):121-8. PubMed ID: 20701853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of human papillomavirus infection as a predictor for recurrence in carcinoma of the cervix after radiotherapy.
    Nagai Y; Toma T; Moromizato H; Maehama T; Asato T; Kariya K; Kanazawa K
    Am J Obstet Gynecol; 2004 Dec; 191(6):1907-13. PubMed ID: 15592271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Papillomavirus-Related Cancers.
    Li Y; Xu C
    Adv Exp Med Biol; 2017; 1018():23-34. PubMed ID: 29052130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of HPV type on prognosis in patients diagnosed with invasive cervical cancer.
    Cuschieri K; Brewster DH; Graham C; Nicoll S; Williams AR; Murray GI; Millan D; Johannessen I; Hardie A; Cubie HA
    Int J Cancer; 2014 Dec; 135(11):2721-6. PubMed ID: 24740764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent human papillomavirus DNA is associated with local recurrence after radiotherapy of uterine cervical cancer.
    Song YJ; Kim JY; Lee SK; Lim HS; Lim MC; Seo SS; Kang S; Lee DO; Park SY
    Int J Cancer; 2011 Aug; 129(4):896-902. PubMed ID: 21064095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes.
    Senapati R; Nayak B; Kar SK; Dwibedi B
    PLoS One; 2017; 12(11):e0187844. PubMed ID: 29161285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus prevalence in women with normal cytology and with cervical cancer in Natal, Brazil.
    Fernandes JV; Meissner Rde V; Carvalho MG; Fernandes TA; Azevedo PR; de Azevedo JW; de Araújo JM
    Mol Med Rep; 2011; 4(6):1321-6. PubMed ID: 21887467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of HPV DNA status in cervical cancer before treatment: a systematic review and meta-analysis.
    Li P; Tan Y; Zhu LX; Zhou LN; Zeng P; Liu Q; Chen MB; Tian Y
    Oncotarget; 2017 Sep; 8(39):66352-66359. PubMed ID: 29029517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus types 16 and 18 and the prognosis of patients with stage I cervical cancer.
    Zampronha Rde A; Freitas-Junior R; Murta EF; Michelin MA; Barbaresco AA; Adad SJ; Oliveira AM; Rassi AB; Oton GJ
    Clinics (Sao Paulo); 2013 Jun; 68(6):809-14. PubMed ID: 23778490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence, distribution, and viral burden of all 15 high-risk human papillomavirus types in adenosquamous carcinoma of the uterine cervix: a multiplex real-time polymerase chain reaction-based study.
    Quddus MR; Manna P; Sung CJ; Kerley S; Steinhoff MM; Lawrence WD
    Hum Pathol; 2014 Feb; 45(2):303-9. PubMed ID: 24355194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation p53 expression and human papilloma virus deoxyribonucleic acid with clinical outcome in early uterine cervical carcinoma.
    Ikuta A; Saito J; Mizokami T; Nakamoto T; Yasuhara M; Nagata F; Nakajima M; Matsuo I; Yasuda K; Kanzaki H
    Cancer Detect Prev; 2005; 29(6):528-36. PubMed ID: 16289387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar.
    Mu-Mu-Shwe ; Harano T; Okada S; Aye-Aye-Win ; Khin-Saw-Aye ; Hlaing-Myat-Thu ; Mo-Mo-Win ; Khin-Khin-Oo ; Myo-Khin
    Acta Med Okayama; 2014; 68(2):79-87. PubMed ID: 24743783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers.
    Stolnicu S; Boros M; Hoang L; Almadani N; de Brot L; Baiocchi G; Bonvolim G; Parra-Herran C; Lerias S; Felix A; Roma A; Pesci A; Oliva E; Park K; Soslow RA; Abu-Rustum NR
    Int J Gynecol Cancer; 2021 Feb; 31(2):177-184. PubMed ID: 33177150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.